EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis

Mei Hong, Xue Yin, Wenmei Yan, Wei Guo, Hongmei Liu, Haisheng Yang

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2024.10368 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Mei Hong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The People's Hospital of Wuhai, Wuhai, China. Hauptthemen laut MEDLINE: Connective Tissue Diseases, Lung Diseases, Interstitial, Mucin-1. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Connective tissue disease-associated interstitial lung disease (CTD-ILD) is an important underlying cause of morbidity and mortality in patients with CTD. Serum Krebs von den Lungen-6 (KL-6) is an immune factor which has been related to the severity of ILD. This systematic review and meta-analysis aimed to evaluate the association between serum KL-6 and mortality of patients with CTD-ILD. Longitudinal studies relevant to the aim of the meta-analysis were retrieved by search of electronic databases including PubMed, Web of Science, and Embase. A random-effects model was used to combine the data by incorporating the influence of between-study heterogeneity. Fifteen cohorts involving 1737 patients with CTD-ILD were included. During a mean follow-up of 35.3 months, 430 (24.8%) patients died. Compared to those with a lower KL-6 at admission, patients with a higher KL-6 were associated with a higher mortality risk during follow-up (risk ratio: 2.18, 95% confidence interval: 1.66 to 2.87, P < 0.001; I2 = 20%). Subgroup analysis showed a significant association in studies from Asian countries, but not in those from non-Asian countries; in studies with cutoff of KL-6 derived in receiver operating characteristic (ROC) curve analysis, but not in those derived from other methods; in studies with multivariate analysis, but not in those with univariate analysis (P for subgroup difference all < 0.05). The association was not significantly affected by different CTDs or methods for measuring serum KL-6. In conclusion, a high serum KL-6 may be a risk factor of increased mortality in patients with CTD-ILD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Connective Tissue DiseasesLung Diseases, InterstitialMucin-1HumansBiomarkers

Substanzen

BiomarkersMUC1 protein, humanMucin-1

Autor:innen und Institutionen

  • Department of Dermatology, The People's Hospital of Wuhai, Wuhai, China.
  • Department of Pulmonary and Critical Care Medicine, The People's Hospital of Wuhai, Wuhai, China.

Zitieren

APA

Hong, M., Yin, X., Yan, W., Guo, W., Liu, H., & Yang, H. (2024). Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10368

Vancouver

Hong M, Yin X, Yan W, Guo W, Liu H, Yang H. Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10368

BibTeX
@article{Hong2024,
  author = {Hong, Mei and Yin, Xue and Yan, Wenmei and Guo, Wei and Liu, Hongmei and Yang, Haisheng},
  title = {Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2024.10368}
}
Kostenlos starten →